1. Home
  2. NAMS vs POWL Comparison

NAMS vs POWL Comparison

Compare NAMS & POWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • POWL
  • Stock Information
  • Founded
  • NAMS 2019
  • POWL 1947
  • Country
  • NAMS Netherlands
  • POWL United States
  • Employees
  • NAMS N/A
  • POWL N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • POWL Electrical Products
  • Sector
  • NAMS Health Care
  • POWL Energy
  • Exchange
  • NAMS Nasdaq
  • POWL Nasdaq
  • Market Cap
  • NAMS 3.1B
  • POWL 3.6B
  • IPO Year
  • NAMS N/A
  • POWL N/A
  • Fundamental
  • Price
  • NAMS $38.74
  • POWL $378.23
  • Analyst Decision
  • NAMS Strong Buy
  • POWL Strong Buy
  • Analyst Count
  • NAMS 10
  • POWL 1
  • Target Price
  • NAMS $43.70
  • POWL $312.00
  • AVG Volume (30 Days)
  • NAMS 1.3M
  • POWL 263.8K
  • Earning Date
  • NAMS 11-06-2025
  • POWL 11-18-2025
  • Dividend Yield
  • NAMS N/A
  • POWL 0.28%
  • EPS Growth
  • NAMS N/A
  • POWL 34.62
  • EPS
  • NAMS N/A
  • POWL 14.40
  • Revenue
  • NAMS $64,006,000.00
  • POWL $1,081,398,000.00
  • Revenue This Year
  • NAMS N/A
  • POWL $10.63
  • Revenue Next Year
  • NAMS N/A
  • POWL $5.98
  • P/E Ratio
  • NAMS N/A
  • POWL $26.23
  • Revenue Growth
  • NAMS 762.15
  • POWL 14.32
  • 52 Week Low
  • NAMS $14.06
  • POWL $146.02
  • 52 Week High
  • NAMS $41.47
  • POWL $413.00
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 66.43
  • POWL 64.36
  • Support Level
  • NAMS $35.50
  • POWL $375.34
  • Resistance Level
  • NAMS $39.03
  • POWL $413.00
  • Average True Range (ATR)
  • NAMS 2.30
  • POWL 20.00
  • MACD
  • NAMS -0.16
  • POWL 3.11
  • Stochastic Oscillator
  • NAMS 61.67
  • POWL 70.03

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

Share on Social Networks: